Find Federal Grants
Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) - Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-20-004
BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa - Data Coordinating Center (DCC) (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-20-010
Limited Competition: Dental, Oral and Craniofacial Tissue Regeneration Consortium (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DE-19-010
Request for Information(RFI)
Mali USAID -Bamako · 72068819RFI00009
Kidney Technology Development Research Education Program (R25 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-19-006
Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · RFA-HL-20-003
Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-215
Centers for Disease Control - NCCDPHP · CDC-RFA-DP19-1903
Ethiopia USAID-Addis Ababa · AID-RFI-663-19-00002
Limited Competition for the Continuation of the Chronic Kidney Disease Biomarkers Consortium (CKD BioCon) Data Coordinating Center (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-19-501
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · PAR-19-214
Health Resources and Services Administration · HRSA-19-002
Health Resources and Services Administration · HRSA-19-089
Health Resources and Services Administration · HRSA-19-085
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
National Institutes of Health · PAR-19-212
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
National Institutes of Health · PAR-19-213
Substance Abuse and Mental Health Services Adminis · TI-19-004
Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-19-015
Corporation for National and Community Service · CNCS-03-06-19
National Institutes of Health · PAR-19-211